Non-Hodgkin Lymphoma Journal Articles

• Safety of Sequential Biological Therapy in IBD Many IBD patients have received multiple classes of biologics due to loss of response or adverse events. Does this increase the risk of serious infections or malignancies?
  Alimentary Pharmacology & Therapeutics, August 03, 2022
• Vedolizumab in Elderly and Nonelderly IBD Patients Is vedolizumab a safe and effective treatment option for both elderly and younger IBD patients?
  Alimentary Pharmacology & Therapeutics, July 20, 2022
• Plerixafor on a WHIM: Promise or Fantasy of a CXCR4 Inhibitor Review emerging data on the use of Plerixafor, a CXCR4 inhibitor, in the treatment of WHIM syndrome (Warts, Hypogammaglobulinemia, Infections and Myelokathexis) and other skin diseases.
  Skin Therapy Letter, June 27, 2022
• Dopamine Use and Its Consequences in the Intensive Care Unit Dopamine is a commonly used treatment in the ICU, but what do we know about the risks associated with its use?
  Critical Care, June 15, 2022
• Screening of Esophageal Varices in HCV+ Cirrhotic Patients This study aimed to evaluate the optimal type, frequency and length of surveillance of esophageal varices in HCV-positive cirrhotic patients who achieved SVR by direct-acting antivirals.
  Liver International, June 13, 2022
• Comorbidities and Co-Medications Among People With HIV How prevalent are comorbidities and the use of non-ART co-medications among people living with HIV?
  HIV Medicine, May 19, 2022
• Thiopurine Discontinuation at Anti-TNF Initiation in IBD Should thiopurine therapy be discontinued in IBD patients when anti-TNF treatment is started? A new study looks at the potential impacts.
  Alimentary Pharmacology & Therapeutics, May 18, 2022
• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Factors for Thyroid Complications After Radiation Therapy How often do cancer patients experience thyroid complications after receiving radiation therapy, and what are the risk factors?
  Clinical Endocrinology, April 29, 2022
• Third mRNA Vaccine in Preventing COVID-19 Hospitalization According to this CDC report, a third dose of an mRNA COVID-19 vaccine significantly increases effectiveness against hospitalization among adults without and with immunocompromising conditions.
  Morbidity & Mortality Weekly Report, April 18, 2022
• Safety and Efficacy of Tofacitinib for Ulcerative Colitis This paper presents final data from OCTAVE Open, an open-label, long-term extension study on the safety and efficacy of the Janus kinase inhibitor tofacitinib for the treatment of ulcerative colitis.
  Alimentary Pharmacology & Therapeutics, March 04, 2022
• Conditions Linked to Severe COVID-19 in Cancer Survivors Many cancer survivors may have one or more underlying conditions, putting them at increased risk for severe COVID-19-associated illness.
  Journal of the National Cancer Institute, February 09, 2022
• Malignancy Risk in Patients With Secukinumab-treated Psoriasis Does treatment with secukinumab increase the risk of malignancy in patients being treated for psoriasis, psoriatic arthritis, or ankylosing spondylitis?
  The British Journal of Dermatology, December 07, 2021
• Diagnostic Workup, Etiology of Hypercalcemia of Malignancy Could new research challenge current thinking about the etiology of hypercalcemia of malignancy?
  Journal of the Endocrine Society, December 02, 2021
• Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA A new analysis investigates the potential for patients with rheumatoid arthritis to experience adverse events after treatment with immune checkpoint inhibitors.
  Journal of Clinical Rheumatology, November 01, 2021
• Risk of Severe Clinical Events After DAA Therapy in HIV/HCV Which severe events may occur after direct-acting antiviral treatment among these patients -- and how common are they?
  HIV Medicine, November 01, 2021
• Radiological Case: Primary Breast Lymphoma Primary breast lymphoma has nonspecific imaging features. Reveiw how the diagnosis of primary breast lymphoma was confirmed in this case presentation.
  Applied Radiology, October 11, 2021
• How I Diagnose Primary Mediastinal Large B-Cell Lymphoma Primary mediastinal, or thymic, large B-cell lymphoma poses a diagnostic challenge. Learn how the authors approach differentiating it from related histologic and biological mimickers in this review.
  American Journal of Clinical Pathology, September 29, 2021
• Benefit of 5ASA Use After Anti-TNF or Immunomodulator in IBD 5ASA is still used as first-line therapy in the treatment of mild to moderate ulcerative colitis. Is there a benefit to continuing it once biological or immunomodulator therapy is initiated?
  Alimentary Pharmacology & Therapeutics, September 29, 2021
• Inguinal Lymphocele After Angiomyomatous Hamartoma Resection Find out how negative pressure wound therapy played a role in the successful treatment of a postoperative lymphocele after angiomyomatous hamartoma resection.
  Wounds, September 03, 2021